DLB Stock Recent News

Dolby and AMC are set to add 40 new Dolby Cinema locations by the end of 2027, raising the total count by 25% to more than 200 nationwide.

Here is how Dolby Laboratories (DLB) and Fox Corporation (FOX) have performed compared to their sector so far this year.

AMC has also selected Dolby Vision as its HDR offering of choice SAN FRANCISCO and LEAWOOD, Kan. , March 31, 2025 /PRNewswire/ --  Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, and AMC Entertainment (NYSE: AMC), the largest theatrical exhibitor in the United States and in the world, today announced a significant expansion of their partnership, following a decade of success and guest popularity of the Dolby Cinema at AMC experience.

Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB) Phase 2 SHINE Data Show Dramatic Slowing of Cognitive Decline with Zervimesine in a Key Pre-specified Alzheimer's Disease Subgroup 2025 Objective: Advance Zervimesine into Late-stage Trials for DLB and Alzheimer's Disease Management will Review Results at 8:00 a.m. ET on Live Webcast and Conference Call PURCHASE, N.Y.

Here is how Dolby Laboratories (DLB) and Netflix (NFLX) have performed compared to their sector so far this year.

Dolby Laboratories (DLB) reported earnings 30 days ago. What's next for the stock?

Strength in Dolby Atmos and Dolby Vision, synergies from acquisitions and focus on shareholder returns make DLB an attractive investment opportunity.

This monthly article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.

Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely.

Dolby Laboratories (DLB) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.